Fora Capital, LLC Puma Biotechnology, Inc. Transaction History

Fora Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$8.98 - $11.6 $31,160 - $40,252	-3,470 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$9.38 - $13.63 $29,368 - $42,675	-3,131 Reduced 47.43%	3,470 $34 Million
Q4 2020 Feb 12, 2021	BUY	$7.78 - $12.13 $51,355 - $80,070	6,601 New	6,601 $67,000
Q3 2020 Nov 13, 2020	SELL	$9.5 - $11.14 $47,319 - $55,488	-4,981 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.01 - $13.24 $34,916 - $65,948	4,981 New	4,981 $52 Million

102

29M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $138M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.